Innova Captab: Investor Presentation for Q4 & FY26 Earnings Call
Innova Captab Limited released its Investor Presentation for Q4 & FY26 results. FY26 revenue reached ₹1,630 Cr (31% YoY growth), with EBITDA at ₹250.3 Cr and PAT at ₹141 Cr. The company highlighted strong growth in CDMO and branded generics businesses. Key certifications were obtained for Baddi and Jammu facilities.
The announcement provides detailed financial results for the fiscal year and quarter, along with strategic updates on business growth, manufacturing capabilities, and market presence, which are material information for investors.
The announcement details strong financial performance with significant year-on-year growth in revenue, EBITDA, and PAT, along with strategic achievements like new certifications and facility ramp-ups, indicating a positive outlook.
Innova Captab Limited has announced its Investor Presentation for the Analysts/Institutional Investor Meeting to discuss the financial results for the quarter and financial year ended March 31, 2026. This follows the intimation of an Earnings Call scheduled for May 8, 2026, at 11:00 A.M. (IST).
The company reported robust financial performance for FY26, with revenues reaching ₹1,630 Crore, a year-on-year growth of 31%. EBITDA stood at ₹250.3 Crore (15.4% margin), and Profit After Tax (PAT) was ₹140.9 Crore (8.6% margin). The company highlighted a strong YoY revenue growth of 42% in Q4 FY26 and 31% in FY26, driven by sustained momentum in both its CDMO and branded generics businesses. Exports contributed 31% to the overall revenue in FY26.
The MD's commentary emphasized the highest-ever annual revenue and strong performance across operations, supported by an expanding product portfolio and increasing customer engagement. Key certifications, including UK-MHRA for the Baddi facility and PIC/S for the Jammu facility, were received, enhancing presence in regulated markets. The Jammu facility has completed its first full year of operations and is ramping up well.
The presentation also detailed the company's journey, manufacturing capabilities across multiple sites (Baddi, Dehradun, Taloja, Kathua), key accreditations, and a comprehensive business model serving over 350 CDMO customers globally and a network of 2,50,000+ touchpoints in India. The company's R&D efforts and experienced management team were also highlighted.
What to do with a filing like this
Innova Captab Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Innova Captab Limited. Read the original for the full detail.